The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Ongoing and anticipated COVID-19 human challenge studies in the UK may advance our understanding of COVID-19 and
facilitate the licensure of safe, effective, and easily deployable next-generation COVID-19 vaccines and boosters. We argue
that international volunteer recruitment for COVID-19 human challenge trials can help promote diversity in these trials and
ensure a sufficient number of eligible volunteers, both of which will increase the benefits of challenge research. We explore
the ethical ramifications of dealing with unfair background conditions of global vaccine injustice to expand medical research,
and conclude that international recruitment for COVID-19 human challenge trials can be conducted ethically provided that
several robust protections are in place for volunteers.
Keywords: human challenge trials, research ethics, COVID-19
https://www.sciencedirect.com/science/article/pii/S1045105621000737?s=09
https://jme.bmj.com/content/early/2021/10/04/medethics-2021-107709
All good.
Well done to Cathal and all the team. Fantastic results.
The Government will continue to work with the life sciences sector to ensure that
effective therapeutics, including antivirals, complement the vaccination programme
to enable the long-term management of COVID-19 and its clinical impacts. The
Government and NHS will set out more details on the availability and administration
of further treatments in due course.
https://twitter.com/InvestorMeetCo/status/1420997058023067649?s=19
https://www.lse.co.uk/ShareChat.asp?ShareTicker=POLB&share=Poolbeg-Pharma
https://www.londonstockexchange.com/stock/POLB/poolbeg-pharma-plc/company-page
Sorry just realized.... Thanks Brendan for your show of support also. :)
14-Jul-21 14-Jul-21 Buy Cathal Friel 26.50 GBX 1,132,075 42,179,056
To some people that is massive. Thanks Cathal for the show of support.
Completion of CHIMagents acquisition
Separately, and further to the Company's announcement of 15 July 2020, Open Orphan announces that it has completed its acquisition of CHIMagents Limited. CHIMagents was established to assist in the design, manufacture and testing of challenge agents for use in challenge studies. The CHIMagents team have been working alongside the Open Orphan team since July 2020 supporting the design, manufacture and testing of both new challenge agents and the Company's industry leading portfolio of existing challenge study agents.
https://twitter.com/MlSTER__X/status/1413408680876417029?s=19
Thanks all. I am not trading. Have balls deep orph and whatever I get in Poolbeg. Can't wait to see the ticker up and running. Never got free shares in a new co before.
cheers. I was searching for a share price or a ticker. I presume that will take a while to go live? 9 months or sooner?
Any update on Poolbeg? Did I read someyhing about 3pm today being cut off point to get shares?
https://twitter.com/chasrutledge/status/1412664587535671297?s=19